Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Jul 21, 2023

SELL
$63.71 - $70.74 $84,543 - $93,871
-1,327 Reduced 25.89%
3,799 $242,000
Q1 2023

Apr 17, 2023

SELL
$65.71 - $74.53 $28,321 - $32,122
-431 Reduced 7.76%
5,126 $355,000
Q4 2022

Jan 25, 2023

SELL
$68.48 - $81.09 $3.7 Million - $4.38 Million
-54,015 Reduced 90.67%
5,557 $0
Q3 2022

Oct 12, 2022

BUY
$0.13 - $76.84 $81 - $48,255
628 Added 1.07%
59,572 $4.24 Million
Q2 2022

Jul 11, 2022

BUY
$72.62 - $79.98 $39,214 - $43,189
540 Added 0.92%
58,944 $4.54 Million
Q1 2022

Apr 14, 2022

BUY
$61.48 - $73.72 $186,776 - $223,961
3,038 Added 5.49%
58,404 $4.27 Million
Q4 2021

Feb 02, 2022

BUY
$53.63 - $62.52 $193,711 - $225,822
3,612 Added 6.98%
55,366 $3.45 Million
Q3 2021

Nov 15, 2021

BUY
$59.17 - $69.31 $1.64 Million - $1.92 Million
27,747 Added 115.58%
51,754 $3.06 Million
Q2 2021

Jul 22, 2021

SELL
$61.91 - $67.42 $103,451 - $112,658
-1,671 Reduced 6.51%
24,007 $1.6 Million
Q1 2021

Apr 14, 2021

SELL
$59.34 - $66.74 $27,237 - $30,633
-459 Reduced 1.76%
25,678 $1.62 Million
Q4 2020

Feb 02, 2021

SELL
$57.74 - $65.43 $149,835 - $169,790
-2,595 Reduced 9.03%
26,137 $1.62 Million
Q3 2020

Nov 12, 2020

SELL
$57.43 - $63.64 $240,344 - $266,333
-4,185 Reduced 12.71%
28,732 $1.73 Million
Q2 2020

Sep 29, 2020

SELL
$54.82 - $64.09 $89,795 - $104,979
-1,638 Reduced 4.74%
32,917 $1.94 Million
Q1 2020

May 15, 2020

SELL
$46.4 - $67.43 $158,409 - $230,206
-3,414 Reduced 8.99%
34,555 $1.93 Million
Q4 2019

Jan 09, 2020

SELL
$49.21 - $64.19 $12,499 - $16,304
-254 Reduced 0.66%
37,969 $2.44 Million
Q3 2019

Oct 24, 2019

SELL
$42.77 - $50.71 $255,379 - $302,789
-5,971 Reduced 13.51%
38,223 $1.94 Million
Q2 2019

Aug 08, 2019

SELL
$44.62 - $49.34 $32,527 - $35,968
-729 Reduced 1.62%
44,194 $2 Million
Q1 2019

May 15, 2019

BUY
$45.12 - $53.8 $2.03 Million - $2.42 Million
44,923 New
44,923 $2.06 Million

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $125B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Rba Wealth Management, LLC Portfolio

Follow Rba Wealth Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Rba Wealth Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Rba Wealth Management, LLC with notifications on news.